With more than 1.6 million new cases of cancer occurring each year, anticancer medications are in high demand. Escalating prescription drug prices have become a significant concern. Anticancer medications are among the most expensive prescription medications, many of them exceeding $100 000 a year. The survival benefits of certain newer anticancer medications may be a few months more than that from the existing treatment but at a much higher price tag. Drug cost may play a substantial role in making treatment choices. Multiple factors leading to high prices and some potential solutions to lower them have been highlighted.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/1060028017702406 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!